Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2010

View Archived Issues

SkyePharma receives FDA complete response letter regarding NDA for Flutiform

FDA sets PDUFA date for Genzyme's BLA for Lumizyme

Biogen and Swedish Orphan Biovitrum initiate dosing in B-LONG trial of rFIXFc in hemophilia B

Bayer to discontinue phase II trial of recombinant liposomal factor VIII

Clinical data shows nilotinib to be an effective front-line treatment for CML

Clinical data show safety and efficacy of dasatinib as initial therapy for CML

Shionogi discloses N-type calcium channel blockers as analgesics

Dana-Farber Cancer Institute claims novel antimalarials

Novel prostacyclin and carbaprostacyclin prodrugs in early development at Gilead

Amnestix describes novel kinase inhibitors for the treatment of cognitive disorders

Merck KGaA claims tyrosine kinase inhibitors for the treatment of cancer

Spectrum meets with FDA regarding Fusilev sNDA for colorectal cancer

Proangiogenic gene therapy reduces ventricular remodeling in diabetic rats

Roche presents OX-2 receptor antagonists for the treatment of sleep disorders

KV-11 shows preclinical potential as ocular antiangiogenic therapy

Affymax completes treatment in phase III trial of Hematide for anemia in CRF

Janssen-Cilag notifies EMEA of withdrawal of Comfyde MAA for partial-onset seizures

Merck & Co. claims novel PET imaging agents for the diagnosis of AD

Osiris completes enrollment in phase II trial of Prochymal in type 1 diabetes

Prolor Biotech reports preclinical results on interferon beta-CTP for multiple sclerosis

Anadys provides progress update on phase II study of ANA-598 in hepatitis C

EMEA recommends additional measures to manage risk for PML with Tysabri therapy

CHMP recommends suspension of marketing authorization for sibutramine

Transition Therapeutics reports results from phase II trial of TT-223 in type 2 diabetes

European Commission approves Bristol-Myers' Orencia in combination with MTX for pJIA

Dr. Reddy's and Aegis sign partnership agreement on Intravail drug delivery technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...